Search Results

35,830 Results for "mercury biomed".

Sort By

Press Releases

Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors

With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector

October 1, 2024
·
2 min read
Press Releases

Psyence Biomed Announces $2.0 Million Private Placement

December 23, 2024
·
6 min read
Drug Development

BioMed X Start Collaboration in Autoimmunity Research with Servier

The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

June 26, 2024
·
3 min read
Business

Mercury Bio Joins the Alliance for mRNA Medicines

Mercury Bio today announced that it has joined the Alliance for mRNA Medicines as a charter member, and that Chief Science Officer Richard Sayre, Ph.D. has joined the Alliance for mRNA Medicines (AMM) board.

January 23, 2024
·
2 min read
Press Releases

Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial

December 17, 2024
·
6 min read
Press Releases

NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape

December 23, 2024
·
11 min read
Business

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update.

May 13, 2024
·
13 min read
Press Releases

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

November 7, 2024
·
4 min read
Press Releases

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

November 27, 2024
·
2 min read
Press Releases

Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed’s Phase IIb Palliative Care Trial

December 17, 2024
·
5 min read